Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for preoperative anxiety and emergence agitation in pediatric day-case adenotonsillectomy
ChiCTR2400087181Phase 4Not yet recruiting
- Sponsor
- Shenzhen Children's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and midazolam in preoperative anxiety and Emergence agitation (EA) (7 arms), sponsored by Shenzhen Children's Hospital. Primary endpoints: Number of cases with Ramsay sedation score >=3 before entering the operating room, Modified Yale Preoperative Anxiety Scale score and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
preoperative anxietyEmergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2400087181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087181.